Page last updated: 2024-12-07

20,22-dihydrodigitoxigenin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

20,22-dihydrodigitoxigenin: cardiotonic steroid [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID107549
CHEMBL ID2068952
SCHEMBL ID10403092
MeSH IDM0067830

Synonyms (10)

Synonym
einecs 224-612-4
dihydrodigitoxigenin
20,22-dihydrodigitoxigenin
cardanolide, 3,14-dihydroxy-, (3-beta,5-beta)-
CHEMBL2068952
5-beta-cardanolide, 3-beta,14-dihydroxy-
4427-85-4
SCHEMBL10403092
3,14-dihydroxycardanolide
DTXSID30963199
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID1135908Inhibition of rat brain (Na+,K+)ATPase incubated for 10 mins followed by Kcl added in presence of appropriate Mg2+ and Na+1979Journal of medicinal chemistry, May, Volume: 22, Issue:5
Cardenolide analogues. 4. (20R)- and (20S)-Cardanolides: on the roles of the 20(22)-ene and 14beta-hydroxyl in genin activity.
AID1135907Inhibition of rat brain (Na+,K+)ATPase in presence of appropriate Mg2+ and Na+1979Journal of medicinal chemistry, May, Volume: 22, Issue:5
Cardenolide analogues. 4. (20R)- and (20S)-Cardanolides: on the roles of the 20(22)-ene and 14beta-hydroxyl in genin activity.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (75.00)18.7374
1990's0 (0.00)18.2507
2000's1 (12.50)29.6817
2010's1 (12.50)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.13

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.13 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.13)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]